NEI Research News

In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis (ranibizumab) when vision was 20/50 or worse.

People are bad at staying focused. We’ve all had our minds wander when we try to concentrate on a task that requires paying close attention but isn’t all that engaging.

A team of scientists has established that a breakdown in communication between two biochemical pathways in the eye is involved in causing cataracts.

A class of medications long used to curb HIV infection shows promise as a therapy for age-related macular degeneration (AMD), suggest findings from an NIH-funded study.

Newly published research provides the first demonstration of how a genetic mutation associated with a common form of albinism leads to the lack of melanin pigments that characterizes the condition.

A new study finds that in learning a visual task, older people exhibited a surprising degree of plasticity, but had trouble filtering out irrelevant information.

For some people it feels like a speck of sand in the eye, or stinging or burning that doesn’t go away. For others, dry eye disease (or simply dry eye) can become a chronic condition that leads to blurred vision or even vision loss if it goes untreated.

In a unique study of human ocular cells, a multi-institution research team finds that glaucoma appears to be a consequence of mechanical dysfunction of a thin layer of cells that is the final barrier to fluid entering Schlemm's canal.

A new study reveals how neurons in the part of the brain responsible for recognizing objects respond to being shown a barrage of images.

Research at Washington University School of Medicine in St. Louis may have implications for treating diseases involving abnormal blood vessel growth, such as the impaired wound healing often seen in diabetes.